New perspectives in the diagnostic approach to the acute coronary syndrome;L'approccio diagnostico alla sindrome coronarica acuta. Nuove prospettive

Recenti Progressi in Medicina

Volumn 96, Issue 4, 2005, Pages

  Montagnana, Martina ^a   Lippi, Giuseppe ^a,b   Guidi, Gian Cesare ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Acute coronary syndrome; Acute myocardial infarction; Ischemia modified albumin; Natriuretic peptide; Troponin

Indexed keywords

ALBUMIN; BRAIN NATRIURETIC PEPTIDE; TROPONIN;

CARDIOVASCULAR DISEASE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DISEASE MARKER; DISEASE SEVERITY; ECHOCARDIOGRAPHY; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HOSPITAL ADMISSION; HUMAN; PRACTICE GUIDELINE; PROGNOSIS; PROTEIN MODIFICATION; REVIEW; RISK FACTOR; THORAX PAIN; UNSTABLE ANGINA PECTORIS; WORLD HEALTH ORGANIZATION;

ACUTE DISEASE; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; HUMANS; MYOCARDIAL INFARCTION; PROGNOSIS; SYNDROME; TROPONIN;

EID: 22844442207     PISSN: 00341193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Zazzaro B. Flogosi e aterosclerosi. Recenti Prog Med 2004; 95: 153-6.
2. Rosalki SB, Roberts R, Katus HA, Giannitsis E, Ladenson JH. Cardiac biomarkers for detection of myocardial infarction: perspectives from fast to present. Clin Chem 2004; 50: 2205-13.
3. Fox KAA, Birkhead J, Wilcox R, Knight C, Barth J. British Cardiac Society Working Group on the definition of myocardial infarction. Heart 2004; 90: 603-9.
4. Karras DJ, Kane DL. Serum markers in the Emergency Department for the diagnosis of acute myocardial infarction. Emerg Med Clin North Am 2001; 19: 321-37.
5. Ohman EM, Casey C, Bengtson JR, Pryor D, Tormey W, Horgan JH. Early detection of acute myocardial infarction: additional diagnostic information from serum concentrations of myoglobin in patients without ST elevation. Br Heart J 1990; 63: 335-8.
6. Panteghini M, Pagani F, Bonetti G. The sensitivity of cardiac markers: an evidence-based approach. Clin Chem Lab Med 1999; 37: 1097-106.
7. French JK, White HD. Clinical implications of the new definition of myocardial infarction. Heart 2004; 90:99-106.
8. Ryan TJ, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel B, Russell RO, Smith EE 3rd, Weaver WD, Gibbons RJ, Alpert JS, Eagle KA, Gardner TJ, Garson A Jr, Gregoratos G, Ryan TJ, Smith SC Jr. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Committee on Management of Acute Myocardial Infarction. J Am Coll Cardiol 1999; 34: 890-911.
9. Panteghini M. Role and importance of biochemical markers in clinical cardiology. Eur Heart J 2004; 25: 1187-96.
10. Myocardial Infarction Redefined - A Consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000; 36: 959-68.
11. Penttila I, Penttila K, Rantanen T. Laboratory diagnosis of patients with acute chest pain. Clin Chem Lab Med 2000; 38: 187-97.
12. Wu AH. Analytical and clinical evaluation of new diagnostic tests for myocardial damage. Clin Chim Acta 1998; 272: 11-21.
13. Christenson RH, Duh SH, Sanhai WR, Wu AH, Holtman V, Painter P, Branham E, Apple FS, Murakami M, Morris DL. Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 2001; 47: 464-70.
14. Roy D, Quiles J, Aldama G, Sinha M, Avanzas P, Arroyo-Espliguero R, Gaze D, Collinson P, Carlos Kaski J. Ischemia Modified Albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int J Cardiol 2004; 97: 297-301.
15. Roy D, Quiles J, Sharma R, Sinha M, Avanzas P, Gaze D, Kaski JC. Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise induced skeletal muscle ischemia. Clin Chem 2004; 50: 1656-60.
16. Anwaruddin S, Januzzi Jr JL, Baggish AL, Lewandrowski L, Lewandrowski KB. Ischemia-modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department setting. Am J Clin Pathol 2005; 123: 140-5.
17. Gidenne S, Ceppa F, Fontan E, Perrier F, Burnat P. Analytical performance of the Albumin Cobalt Binding (ACB) test on the Gobas MIRA Plus analyzer. Clin Chem Lab Med 2004; 42: 455-61.
18. Bayes-Genis A, Conover CA, Overgaard MT, Bailey KR, Christiansen M, Holmes DR Jr, Virmani R, Oxvig C, Schwartz RS. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 2001; 345: 1022-9.
19. Heeschen C, Dimmeler S, Hamm CW, Fichtischerer S, Simoons ML, Zeiher AM. CAPTURE Study Investigators. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. Am Coll Cardiol 2005; 45: 229-37.
20. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 1992; 326: 242-50.
21. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med 1992; 326: 310-8.
22. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr; American College of Cardiology; American Heart Association; Canadian Cardiovascular Society. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction - Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 2004; 44: 671-719.
23. Galvani M, Ferrini D, Ghezzi F, Ottani F. Cardiac markers and risk stratification: an integrated approach. Clin Chim Acta 2001; 311: 9-17.
24. Menown IB, Mathew TP, Gracey HM, Nesbitt GS, Murray P, Young IS, Adgey AA. Prediction of recurrent events by D-dimer and inflammatory markers in patients with normal cardiac troponin I (PREDICT) Study. Am Heart J 2003; 145: 986-92.
25. Andrè P, Nannizzi-Alaimo L, Prasad SK, Philips DR. Platelet-derived CD40L. The switch-hitting player of cardiovascular diseases. Circulation 2002; 106: 896-99.
26. Lippi G, Mengoni A, Manzato F. Plasma D-dimer in the diagnosis of deep vein thrombosis. JAMA 1998; 280: 1828-9.
27. James SK, Lindahl B, Siegbahn A, Stridsberg M, Venge P, Armstrong P, Barnathan ES, Califf R, Topol EJ, Simoons ML, Wallentin L. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease. Circulation 2003; 108: 275-81.
28. de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet 2003; 362: 316-22.
29. Plebani M, Zaninotto M. Sindromi coronariche acute senza sopraslivellamento del tratto ST. Attuali linee-guida. Recenti Prog Med 2002; 93: 515-8.